814 - Phase Iii Randomized Controlled Trial to Compare...

Gastroenterology 2018 / 05 Vol. 154; Iss. 6

814 - Phase Iii Randomized Controlled Trial to Compare Biosimilar Infliximab (CT-P13) with Innovator Infliximab in Patients with Active Crohn's Disease: 1-Year Maintenance and Switching Results

Ye, Byong Duk, Kim, Young Ho, Pesegova, Marina, Alexeeva, Olga, Osipenko, Marina, Lahat, Adi, Dorofeyev, Andriy, Salamon, Agnes, Fishman, Sigal, Levchenko, Olena, Cheon, Jae Hee, Scribano, Maria Lia,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
154
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(18)30972-7
Date:
May, 2018
File:
PDF, 1.03 MB
english, 2018
Conversion to is in progress
Conversion to is failed